European Pharmaceutical Review

MAY 17, 2023

The study enrolled 49 patients with recurrent GBM from several institutions between September 2016 to January 2019. “After injection, patients that respond well develop inflammation inside the tumour, triggering an immune response that first kills the virus.” The median age of patients was 53 years and 41 percent were women.

Engineering 98

Engineering Side effects Medicine Patients 98

Clarivate

JANUARY 3, 2023

Starting with 12,160 Research Fronts, representing papers published and cited between 2016 and 2021, the next step was to select the fronts containing core literature that is both highly cited and recent – an indicator of particularly active and fast-moving research.

Specialization 98

Specialization Side effects Management Medicine 98

European Pharmaceutical Review

JULY 20, 2022

Monitoring and studying the side effects of licensed medicines is an essential part of drug development to ensure public safety. This is usually on a much larger scale than is possible in clinical trials and can uncover less common side effects. Supporting regulators. Study focus. almitrine – a respiratory stimulant.

Medicine 97

Medicine Safety Side effects Electronics 97

European Pharmaceutical Review

DECEMBER 14, 2023

Our research showed that in Europe between 1999 and 2016, 35 products were withdrawn. 1,2 This signals a promising trend towards a more comprehensive and diversified approach in regulatory decision-making. Meta-analyses contributed least frequently (31.4

Medicine 116

Medicine Safety Competition Medical 116

Medgadget

MAY 2, 2023

These treatments at times come with a long list of side effects, leaving many patients in search of an effective long-term solution. For some patients with PTSD, psychotherapy may not be an effective option, they may find talking about their traumatic experience stress inducing, untherapeutic or ineffective.

Side effects 86

Side effects Prescription Healthcare Healthcare 86

pharmaphorum

JANUARY 6, 2023

In the phase 3 trial, TAK-755 reduced the incidence of thrombocytopenia events by 60% compared to plasma-based treatment and was much better tolerated, with less than 9% of patients on Takeda’s drug reporting side effects compared to almost half (48%) of those on standard therapy.

Side effects 59

Side effects Patients Sales Management 59

European Pharmaceutical Review

JUNE 12, 2024

The specific representation of these events differed between the treatments, highlighting potential differences in side effect profiles that should be explored in further studies. 2016; 46: 479–93. Adverse events were relatively low in both groups (2.22 percent for MBK-01 and 4.26 percent for fidaxomicin). Intern Med J.

Safety 111

Safety Patients Side effects Management 111

Clarivate

SEPTEMBER 25, 2024

A ‘magic bullet’ medicine that can cure a disease quickly and completely, [1] without deleterious side effects. [2] 6] As many pathogenetic targets have multiple physiological functions, highly specific ‘magic bullets’ may impact multiple cellular pathways simultaneously, causing unintended side effects.7 Chin J Cancer.

Medicine 59

Medicine Side effects Patients Pharmaceutical 59

Clarivate

JUNE 26, 2023

The agency refers to their 2016 Guidance for Industry on Patient Preference Information Submission — which, though a useful document, does not provide clear requirements for how to run a quantitative preference study, suggesting the Guidance is intended to be used as a catalyst for advancement in this space.

Food and Drug Administration 52

Food and Drug Administration Patients Side effects Medicine 52

European Pharmaceutical Review

NOVEMBER 4, 2022

based treatment concomitant with reductions in traditionally unavoidable and problematic side effects. Patient Preference and Adherence, 2016. The importance of taxanes in oncology. Taxanes have played an important role in anticancer treatment for several decades. Krohe M, Eek D, Mazar I, et al. Volume 10, pp.1609–1621.

Food and Drug Administration 98

Food and Drug Administration Pharmaceutical FDA Patients 98

European Pharmaceutical Review

SEPTEMBER 5, 2024

Advanz Pharma, which markets the drug in Europe, needed confirmatory data from further clinical studies to maintain its conditional marketing authorisation granted in 2016. Due to the issues with Ocaliva, there is space for competitors with fewer side effects and Calliditas hopes that setanaxib will fit the bill.

Medicine 59

Medicine Side effects Marketing Patients 59

European Pharmaceutical Review

SEPTEMBER 22, 2023

While new positive clinical data with anti-Abeta mAbs signal tremendous advancement and proof‑of-concept for the whole field, it is believed that the observed effects could still be improved and optimised in terms of greater clinical benefits, lower side effects and enhanced treatment convenience.

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97

PM360

AUGUST 26, 2024

As cost constraints and care rationing under the transition to corporatist “value-based” care, any reduction in cost, misdiagnosis, non-targeted treatment, and unnecessary side effects must shift focus of care from reaction to prediction, and from Rx cycling to prevention.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Pharmaceutical Technology

JUNE 20, 2023

Since some drugs and medical products can have severe side effects if used incorrectly, MT engines used to translate such critical information such as dosage instructions, must be checked and edited by human translators.

Electronics 52

Electronics Medical Training Healthcare 52